H2 receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for H2 receptor antagonist, covering 2017-04-21 to 2017-04-21. Get the full timeline:
Most recent: Clinical Trial Update: ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA [Phase 3]